Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test the safety and effectiveness of IDN-6556 in preventing
liver damage that normally occurs when livers are transported before being transplanted and
in the immediate post-transplant period.